Community‐Onset Methicillin‐ResistantStaphylococcus aureusAssociated with Antibiotic Use and the Cytotoxin Panton‐Valentine Leukocidin during a Furunculosis Outbreak in Rural Alaska | Zendy

Henry C. Baggett | Zendy; Thomas W. Hennessy | Zendy; Karen Rudolph | Zendy; Dana Bruden | Zendy; Alisa Reasonover | Zendy; Alan J. Parkinson | Zendy; Rachel Sparks | Zendy; Rodney M. Donlan | Zendy; Patricia Martinez | Zendy; Kanokporn Mongkolrattanothai | Zendy; Jay C. Butler | Zendy

Open Access

Community‐Onset Methicillin‐ResistantStaphylococcus aureusAssociated with Antibiotic Use and the Cytotoxin Panton‐Valentine Leukocidin during a Furunculosis Outbreak in Rural Alaska

Author(s) -

Henry C. Baggett,

Thomas W. Hennessy,

Karen Rudolph,

Dana Bruden,

Alisa Reasonover,

Alan J. Parkinson,

Rachel Sparks,

Rodney M. Donlan,

Patricia Martinez,

Kanokporn Mongkolrattanothai,

Jay C. Butler

Publication year - 2004

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/383247

Subject(s) - panton–valentine leukocidin , outbreak , staphylococcus aureus , methicillin resistant staphylococcus aureus , leukocidin , pulsed field gel electrophoresis , microbiology and biotechnology , medicine , antibiotics , odds ratio , staphylococcal skin infections , staphylococcal infections , meticillin , skin infection , micrococcaceae , antibacterial agent , virology , biology , genotype , bacteria , biochemistry , gene , genetics

Community-onset methicillin-resistant Staphylococcus aureus (CO-MRSA) reports are increasing, and infections often involve soft tissue. During a CO-MRSA skin infection outbreak in Alaska, we assessed risk factors for disease and whether a virulence factor, Panton-Valentine leukocidin (PVL), could account for the high rates of MRSA skin infection in this region.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research